The Carlyle Group Inc. 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-21 4:31 pm Sale |
2024-10-17 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
2,003,101 4.990% |
-464,998 (-18.84%) |
Filing |
| 2024-10-15 4:31 pm Sale |
2024-10-10 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
2,468,099 6.200% |
-782,979 (-24.08%) |
Filing |
| 2024-10-10 4:30 pm Sale |
2024-10-08 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
3,251,078 8.100% |
-745,287 (-18.65%) |
Filing |
| 2024-09-10 6:30 pm Purchase |
2024-09-06 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
3,996,365 9.990% |
1,102,750 (+38.11%) |
Filing |
| 2023-10-16 4:30 pm Purchase |
2023-10-12 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
2,893,615 9.990% |
1,326,368 (+84.63%) |
Filing |
| 2023-10-03 4:05 pm Purchase |
2023-09-28 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
1,567,247 9.990% |
339,930 (+27.70%) |
Filing |
| 2023-08-18 4:15 pm Purchase |
2023-08-08 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
1,227,317 12.300% |
1,227,317 (New Position) |
Filing |
| 2023-05-10 4:32 pm Unchanged |
2023-05-08 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
0 0.000% |
0 (Unchanged) |
Filing |
| 2022-12-20 4:30 pm Sale |
2022-12-16 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
0 0.000% |
-1,224,571 (Position Closed) |
Filing |
| 2022-08-11 4:56 pm Purchase |
2022-08-01 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
1,224,571 15.300% |
1,224,571 (New Position) |
Filing |